bi-dentate c-Jun N-terminal kinase inhibitors (Sanford Burnham Medical Research Institute)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namebi-dentate c-Jun N-terminal kinase inhibitors (Sanford Burnham Medical Research Institute)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase inhibitors
Targetsc-Jun N-terminal kinase
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanford Burnham Prebys Medical Discovery Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanford Burnham Prebys Medical Discovery Institute
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A